Liver cancer remains a global health challenge, with an estimated incidence of> 1 million
cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer …

Importance Long-term oncologic outcomes of robotic surgery remain a hotly debated topic in
surgical oncology, but sparse data have been published thus far. Objective To analyze short …

A high rate of recurrence after curative therapy is a major challenge for the management of
hepatocellular carcinoma (HCC). Currently, no effective adjuvant therapy is available to …

Primary liver cancer was the third most common cause of death due to cancer worldwide in
2020, and the incidence continues to grow. 1 By 2025, it has been estimated that more than …

Background Ferroptosis is an important iron‐dependent form of cell death in hepatocellular
carcinoma (HCC). Sorafenib, a potent ferroptosis inducer, is used to treat advanced HCC but …

Objective: To evaluate whether this conversion rate to resectability could be increased when
patients are treated with transarterial chemoembolization and hepatic arterial infusion …

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the third
leading cause of cancer-related deaths globally. Hepatic arterial infusion chemotherapy …

The recurrence rate remains high even under nucleos (t) ide analogues (NUCs) therapy in
patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after resection …

Background Treatment of hepatocellular carcinoma (HCC) is predicated on early diagnosis
such that 'curative therapies' can be successfully applied. The term 'curative'is, however …

Background & Aims Herein, we aimed to establish benchmark values–based on a
composite indicator of healthcare quality–for the performance of laparoscopic left lateral …